{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["COVID-19", "SARS-COV-2", "cytokine storm", "endothelial dysfunction", "immunomodulation", "medical ozone", "ozone", "ozone therapy", "virustatic"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "33004712", "DateCompleted": {"Year": "2020", "Month": "10", "Day": "13"}, "DateRevised": {"Year": "2021", "Month": "05", "Day": "07"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": ["10.4103/2045-9912.289462"], "Journal": {"ISSN": "2045-9912", "JournalIssue": {"Volume": "10", "Issue": "3", "PubDate": {"Year": "2020", "Season": "Jul-Sep"}}, "Title": "Medical gas research", "ISOAbbreviation": "Med Gas Res"}, "ArticleTitle": "Rationale for ozone-therapy as an adjuvant therapy in COVID-19: a narrative review.", "Pagination": {"StartPage": "134", "EndPage": "138", "MedlinePgn": "134-138"}, "Abstract": {"AbstractText": ["Coronavirus disease 2019 (COVID-19) is the respiratory disease caused by the novel severe acute respiratory syndrome-coronavirus-2 and is characterized by clinical manifestations ranging from mild, flu-like symptoms to severe respiratory insufficiency and multi-organ failure. Patients with more severe symptoms may require intensive care treatments and face a high mortality risk. Also, thrombotic complications such as pulmonary embolisms and disseminated intravascular coagulation are frequent in these patients. Indeed, COVID-19 is characterized by an abnormal inflammatory response resembling a cytokine storm, which is associated to endothelial dysfunction and microvascular complications. To date, no specific treatments are available for COVID-19 and its life-threatening complication. Immunomodulatory drugs, such as hydroxychloroquine and interleukin-6 inhibitors, as well as antithrombotic drugs such as heparin and low molecular weight heparin, are currently being administered with some benefit. Ozone therapy consists in the administration of a mixture of ozone and oxygen, called medical ozone, which has been used for over a century as an unconventional medicine practice for several diseases. Medical ozone rationale in COVID-19 is the possibility of contrasting endothelial dysfunction, modulating the immune response and acting as a virustatic agent. Thus, medical ozone could help to decrease lung inflammation, slow down viral growth, regulate lung circulation and oxygenation and prevent microvascular thrombosis. Ozone-therapy could be considered a feasible, cost-effective and easy to administer adjuvant therapy while waiting for the synthesis of a therapy or the development of the vaccine."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit\u00e0 Operativa Semplice Dipartimentale Farmacologia Clinica e Sperimentazione Clinica, Azienda Sanitaria, Potenza, Italy."}], "LastName": "Ranaldi", "ForeName": "Giovanni Tommaso", "Initials": "GT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Geriatrics, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy."}], "LastName": "Villani", "ForeName": "Emanuele Rocco", "Initials": "ER"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Emergency Medicine, Fondazione Policlinico Universitario \"A. Gemelli\" IRCCS, Rome, Italy."}], "LastName": "Franza", "ForeName": "Laura", "Initials": "L"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Australia", "MedlineTA": "Med Gas Res", "NlmUniqueID": "101564536", "ISSNLinking": "2045-9912"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": ["isolation & purification"], "DescriptorName": "Betacoronavirus"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Combined Modality Therapy"}, {"QualifierName": ["physiopathology", "therapy", "virology"], "DescriptorName": "Coronavirus Infections"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": ["physiopathology", "therapy", "virology"], "DescriptorName": "Pneumonia, Viral"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}], "CoiStatement": "None"}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;382:1199\u20131207.", "ArticleIdList": ["PMC7121484", "31995857"]}, {"Citation": "Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574\u20131581.", "ArticleIdList": ["PMC7136855", "32250385"]}, {"Citation": "Li G, Fan Y, Lai Y, et al. Coronavirus infections and immune responses. J Med Virol. 2020;92:424\u2013432.", "ArticleIdList": ["PMC7166547", "31981224"]}, {"Citation": "Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39:529\u2013539.", "ArticleIdList": ["PMC7079893", "28466096"]}, {"Citation": "Franza L, Carusi V, Altamura S, et al. Interrelationship between inflammatory cytokines (IL-1, IL-6, IL-33, IL-37) and acquired immunity. J Biol Regul Homeost Agents. 2019;33:1321\u20131326.", "ArticleIdList": ["31663301"]}, {"Citation": "Stebbing J, Phelan A, Griffin I, et al. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis. 2020;20:400\u2013402.", "ArticleIdList": ["PMC7158903", "32113509"]}, {"Citation": "Zelic M, Roderick JE, O\u2019Donnell JA, et al. RIP kinase 1-dependent endothelial necroptosis underlies systemic inflammatory response syndrome. J Clin Invest. 2018;128:2064\u20132075.", "ArticleIdList": ["PMC5919800", "29664014"]}, {"Citation": "Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res. 2020;220:1\u201313.", "ArticleIdList": ["PMC7158248", "32299776"]}, {"Citation": "Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int. 2020 doi:10.1111/liv.14455.", "ArticleIdList": ["32239796"]}, {"Citation": "Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844\u2013847.", "ArticleIdList": ["PMC7166509", "32073213"]}, {"Citation": "Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420\u2013422.", "ArticleIdList": ["PMC7164771", "32085846"]}, {"Citation": "Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:1\u20139.", "ArticleIdList": ["PMC7149362", "32275288"]}, {"Citation": "Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18\u201322.", "ArticleIdList": ["PMC7146689", "32240762"]}, {"Citation": "Thachil J. The versatile heparin in COVID-19. J Thromb Haemost. 2020;18:1020\u20131022.", "ArticleIdList": ["PMC9906146", "32239799"]}, {"Citation": "Wang J, Hajizadeh N, Moore EE, et al. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series. J Thromb Haemost. 2020 doi:10.1111/jth.14828.", "ArticleIdList": ["PMC7262152", "32267998"]}, {"Citation": "Ding W, Jin W, Cao S, et al. Ozone disinfection of chlorine-resistant bacteria in drinking water. Water Res. 2019;160:339\u2013349.", "ArticleIdList": ["31158616"]}, {"Citation": "Smith NL, Wilson AL, Gandhi J, Vatsia S, Khan SA. Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility. Med Gas Res. 2017;7:212\u2013219.", "ArticleIdList": ["PMC5674660", "29152215"]}, {"Citation": "Bocci V. Autohaemotherapy after treatment of blood with ozone. A reappraisal. J Int Med Res. 1994;22:131\u2013144.", "ArticleIdList": ["8088420"]}, {"Citation": "Bocci V, Valacchi G, Corradeschi F, Fanetti G. Studies on the biological effects of ozone: 8. Effects on the total antioxidant status and on interleukin-8 production. Mediators Inflamm. 1998;7:313\u2013317.", "ArticleIdList": ["PMC1781866", "9883965"]}, {"Citation": "Srisankar EV, Patterson LK. Reactions of ozone with fatty acid monolayers: a model system for disruption of lipid molecular assemblies by ozone. Arch Environ Health. 1979;34:346\u2013349.", "ArticleIdList": ["496433"]}, {"Citation": "Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991;11:81\u2013128.", "ArticleIdList": ["1937131"]}, {"Citation": "Bocci V, Borrelli E, Travagli V, Zanardi I. The ozone paradox: ozone is a strong oxidant as well as a medical drug. Med Res Rev. 2009;29:646\u2013682.", "ArticleIdList": ["19260079"]}, {"Citation": "Huth KC, Saugel B, Jakob FM, et al. Effect of aqueous ozone on the NF-kappaB system. J Dent Res. 2007;86:451\u2013456.", "ArticleIdList": ["17452567"]}, {"Citation": "Cooke ED, Pockley AG, Tucker AT, Kirby JD, Bolton AE. Treatment of severe Raynaud's syndrome by injection of autologous blood pretreated by heating, ozonation and exposure to ultraviolet light (H-O-U) therapy. Int Angiol. 1997;16:250\u2013254.", "ArticleIdList": ["9543222"]}, {"Citation": "Re L, Mart\u00ednez-S\u00e1nchez G, Bordicchia M, et al. Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway in vivo? A preliminary result. Eur J Pharmacol. 2014;742:158\u2013162.", "ArticleIdList": ["25218903"]}, {"Citation": "Wei Y, Chen P, de Bruyn M, Zhang W, Bremer E, Helfrich W. Carbon monoxide-releasing molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats. BMC Gastroenterol. 2010;10:42.", "ArticleIdList": ["PMC2873601", "20444253"]}, {"Citation": "Wu BJ, Midwinter RG, Cassano C, et al. Heme oxygenase-1 increases endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2009;29:1537\u20131542.", "ArticleIdList": ["19542024"]}, {"Citation": "Cao Y, Wang H, Wang Q, Han X, Zeng W. Three-dimensional volume fluorescence-imaging of vascular plasticity in adipose tissues. Molecular metabolism. 2018;14:71\u201381.", "ArticleIdList": ["PMC6034070", "29914852"]}, {"Citation": "Yamanel L, Kaldirim U, Oztas Y, et al. Ozone therapy and hyperbaric oxygen treatment in lung injury in septic rats. Int J Med Sci. 2011;8:48\u201355.", "ArticleIdList": ["PMC3020392", "21234269"]}, {"Citation": "Uludag MO, Ozdemir ED, Bal NB, et al. Effects of ozone treatment in endotoxin induced shock model in rats. Int J Pharmacol. 2017;13:166\u2013174."}, {"Citation": "Zamora ZB, Borrego A, L\u00f3pez OY, et al. Effects of ozone oxidative preconditioning on TNF-alpha release and antioxidant-prooxidant intracellular balance in mice during endotoxic shock. Mediators Inflamm. 2005;2005:16\u201322.", "ArticleIdList": ["PMC1482874", "15770062"]}, {"Citation": "Ranaldi GT. Ossigeno-Ozonoterapia nelle patologie arteriose degli arti inferiori. Int J Ozone Ther. 2007;2:131\u2013132."}, {"Citation": "Liu J, Zhang P, Tian J, et al. Ozone therapy for treating foot ulcers in people with diabetes. Cochrane Database Syst Rev. 2015:CD008474.", "ArticleIdList": ["PMC8246444", "26505864"]}, {"Citation": "Hassanien M, Rashad S, Mohamed N, Elawamy A, Ghaly MS. Non-invasive oxygen-ozone therapy in treating digital ulcers of patients with systemic sclerosis. Acta Reumatol Port. 2018;43:210\u2013216.", "ArticleIdList": ["30414369"]}, {"Citation": "Picca A, Sirago G, Pesce V, et al. Administration of enalapril started late in life attenuates hypertrophy and oxidative stress burden, increases mitochondrial mass, and modulates mitochondrial quality control signaling in the rat heart. Biomolecules. 2018;8:177.", "ArticleIdList": ["PMC6315620", "30563025"]}, {"Citation": "Travagli V, Zanardi I, Bocci V. A realistic evaluation of the action of ozone on whole human blood. Int J Biol Macromol. 2006;39:317\u2013320.", "ArticleIdList": ["16712921"]}, {"Citation": "Balmes JR, Arjomandi M, Bromberg PA, et al. Ozone effects on blood biomarkers of systemic inflammation, oxidative stress, endothelial function, and thrombosis: The Multicenter Ozone Study in oldEr Subjects (MOSES) PLoS One. 2019;14:e0222601.", "ArticleIdList": ["PMC6760801", "31553765"]}, {"Citation": "Li Y, Perry T, Kindy MS, et al. GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc Natl Acad Sci U S A. 2009;106:1285\u20131290.", "ArticleIdList": ["PMC2633544", "19164583"]}, {"Citation": "Dussault PH, George AD, Trullinger TK. Peroxides as oxidative enzyme inhibitors: mechanism-based inhibition of a cysteine protease by an amino acid ozonide. Bioorg Med Chem Lett. 1999;9:3255\u20133258.", "ArticleIdList": ["10576698"]}, {"Citation": "Rowen RJ, Robins H, Carew K, Kamara MM, Jalloh MI. Rapid resolution of hemorrhagic fever (Ebola) in sierra leone with ozone therapy. Afr J Infect Dis. 2015;10:49\u201354."}, {"Citation": "Forsythe RO, Brownrigg J, Hinchliffe RJ. Peripheral arterial disease and revascularization of the diabetic foot. Diabetes Obes Metab. 2015;17:435\u2013444.", "ArticleIdList": ["25469642"]}, {"Citation": "Murugesan N, \u00dcstunkaya T, Feener EP. Thrombosis and hemorrhage in diabetic retinopathy: a perspective from an inflammatory standpoint. Semin Thromb Hemost. 2015;41:659\u2013664.", "ArticleIdList": ["PMC4765320", "26305236"]}, {"Citation": "Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients. AJR Am J Roentgenol. 2020;doi:10. 2214/AJR.20.23034.", "ArticleIdList": ["32174129"]}, {"Citation": "Antoszewski Z, Czyz-Grabi\u0144ska E, Go\u0142ofit Z. Ozone therapy in the management of respiratory failure after long term mechanical respiration. Pol Merkur Lekarski. 2001;11:180\u2013181.", "ArticleIdList": ["11757225"]}, {"Citation": "Bendjelid K, Giraud R. Treating hypoxemic patients with SARS-COV-2 pneumonia: Back to applied physiology. Anaesth Crit Care Pain Med. 2020 doi:10.1016/j.accpm.2020.04.003.", "ArticleIdList": ["PMC7161523", "32305591"]}, {"Citation": "Ruaro B, Smith V, Sulli A, Decuman S, Pizzorni C, Cutolo M. Methods for the morphological and functional evaluation of microvascular damage in systemic sclerosis. Korean J Intern Med. 2015;30:1\u20135.", "ArticleIdList": ["PMC4293547", "25589827"]}, {"Citation": "Zychowski KE, Lucas SN, Sanchez B, Herbert G, Campen MJ. Hypoxia-induced pulmonary arterial hypertension augments lung injury and airway reactivity caused by ozone exposure. Toxicol Appl Pharmacol. 2016;305:40\u201345.", "ArticleIdList": ["PMC4961626", "27286659"]}, {"Citation": "Borrelli E. An integrative approach in the treatment of chronic obstructive pulmonary disease: The role of the ozone therapy. Eur J Integr Med. 2015;7:31."}, {"Citation": "Delaunois A, Segura P, Dessy-Doiz\u00e9 C, et al. Ozone-induced stimulation of pulmonary sympathetic fibers: a protective mechanism against edema. Toxicol Appl Pharmacol. 1997;147:71\u201382.", "ArticleIdList": ["9356309"]}, {"Citation": "Lin L, Xu L, Lv W, et al. An NLRP3 inflammasome-triggered cytokine storm contributes to Streptococcal toxic shock-like syndrome (STSLS) PLoS Pathog. 2019;15:e1007795.", "ArticleIdList": ["PMC6553798", "31170267"]}, {"Citation": "Trzeciak S, Dellinger RP, Parrillo JE, et al. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med. 2007;49:88\u201398, 98.e1-2.", "ArticleIdList": ["17095120"]}, {"Citation": "Lipinska-Gediga M. Sepsis and septic shock-is a microcirculation a main player. Anaesthesiol Intensive Ther. 2016;48:261\u2013265.", "ArticleIdList": ["27660252"]}, {"Citation": "Wujtewicz M, Dylczyk-Sommer A, Aszkie\u0142owicz A, Zdanowski S, Piwowarczyk S, Owczuk R. COVID-19 - what should anaethesiologists and intensivists know about it. Anaesthesiol Intensive Ther. 2020;52:34\u201341.", "ArticleIdList": ["PMC10173133", "32191830"]}, {"Citation": "Park JS, Sung BJ, Yoon KS, Jeong CS. The bactericidal effect of an ionizer under low concentration of ozone. BMC Microbiol. 2016;16:173.", "ArticleIdList": ["PMC4967512", "27475908"]}, {"Citation": "Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol. 2005;77:598\u2013625.", "ArticleIdList": ["15689384"]}, {"Citation": "Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 2016;3:237\u2013261.", "ArticleIdList": ["PMC5457962", "27578435"]}, {"Citation": "Ranaldi GT, Villani ER, Franza L. Ozonetherapy: a multirole weapon, rational of the use of the topical pathway against SARS-COV-2. 2020.  [Assessed by May 6, 2020].  https://frenxiv.org/n2dup/ "}, {"Citation": "Hernandez A, Vinals M, Pablos A, et al.  Ozone therapy for patients with SARS-COV-2 pneumonia: a single-center prospective cohort study. 2020.  [Assessed by June 12, 2020].  https://www.medrxiv.org/content/10.1101/2020.1106.1103.20117994v20117992.full.pdf ."}, {"Citation": "Harch PG. Hyperbaric oxygen treatment of novel coronavirus (COVID-19) respiratory failure. Med Gas Res. 2020;10:61\u201362.", "ArticleIdList": ["PMC7885706", "32541128"]}, {"Citation": "Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009;42:267\u2013278.", "ArticleIdList": ["19233695"]}, {"Citation": "Yazdany J, Kim AHJ. Use of hydroxychloroquine and chloroquine during the COVID-19 pandemic: what every clinician should know. Ann Intern Med. 2020;172:754\u2013755.", "ArticleIdList": ["PMC7138336", "32232419"]}, {"Citation": "Huffman LJ, Judy DJ, Brumbaugh K, et al. Hyperthyroidism increases the risk of ozone-induced lung toxicity in rats. Toxicol Appl Pharmacol. 2001;173:18\u201326.", "ArticleIdList": ["11350211"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "10", "Day": "2", "Hour": "5", "Minute": "36"}, {"Year": "2020", "Month": "10", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "13"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33004712", "PMC8086623", "10.4103/2045-9912.289462", "MedGasRes_2020_10_3_134_289462"]}}], "PubmedBookArticle": []}